0001225208-18-011613.txt : 20180711 0001225208-18-011613.hdr.sgml : 20180711 20180711193831 ACCESSION NUMBER: 0001225208-18-011613 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180702 FILED AS OF DATE: 20180711 DATE AS OF CHANGE: 20180711 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wengel Kathryn E CENTRAL INDEX KEY: 0001745955 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 18949440 MAIL ADDRESS: STREET 1: JOHNSON & JOHNSON STREET 2: ONE JOHNSON & JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0101 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 3 1 doc3.xml X0206 3 2018-07-02 0 0000200406 JOHNSON & JOHNSON JNJ 0001745955 Wengel Kathryn E ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 1 EVP, Chief GSC Officer Common Stock 34290.0363 D Common Stock 17.0000 I By 401k Common Stock 281.0000 I By ESOP Employee Stock Options (Right to Buy) 62.2000 2014-01-11 2021-01-08 Common Stock 8238.0000 D Employee Stock Options (Right to Buy) 62.6200 2013-02-09 2020-02-07 Common Stock 2017.0000 D Employee Stock Options (Right to Buy) 65.3700 2015-01-18 2022-01-17 Common Stock 7877.0000 D Employee Stock Options (Right to Buy) 72.5400 2016-01-17 2023-01-13 Common Stock 56410.0000 D Employee Stock Options (Right to Buy) 90.4400 2017-02-11 2024-02-09 Common Stock 35638.0000 D Employee Stock Options (Right to Buy) 100.0600 2018-02-10 2025-02-09 Common Stock 32762.0000 D Employee Stock Options (Right to Buy) 101.8700 2019-02-09 2026-02-08 Common Stock 38945.0000 D Employee Stock Options (Right to Buy) 115.6700 2020-02-13 2027-02-13 Common Stock 42965.0000 D Employee Stock Options (Right to Buy) 129.5100 2021-02-12 2028-02-11 Common Stock 33044.0000 D Restricted Share Units 2019-02-08 Common Stock 5882.0000 D Restricted Share Units 2021-02-12 Common Stock 1658.0000 D Restricted Share Units 2020-02-13 Common Stock 7592.0000 D Shares held in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (6/30/2018). Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (6/30/2018). Vested and exercisable one day after the third anniversary of the date of the grant. Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock and vests on the third anniversary of the date of grant. wengelpoa.txt Linda E. King, as attorney-in-fact for Kathryn E. Wengel 2018-07-11 EX-24 2 wengelpoa.txt POWER OF ATTORNEY Executive Officers Know all persons by these presents, that the undersigned hereby constitutes and appoints each of Thomas J. Spellman III, Tina French, Linda E. King, Maria Frucci and Michelle Ryan, signing singly, as the undersigned's true and lawful attorneys-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an executive officer of Johnson & Johnson (the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder (the "Exchange Act") and Form 144 in accordance with Rule 144 of the Securities Act of 1933, as amended (the "Securities Act"); (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, 5 and 144 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in -fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys -in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act or Rule 144 of the Securities Act. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file reports pursuant to Section 16 of the Exchange Act with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the date set forth below. /s/ Kathryn E. Wengel Name: Kathryn E. Wengel Date: July 3, 2018